Events
2015-03-03
IAI International Symposium: Innovative Approaches for Drug Development in Academia [Agenda]
Tuesday, March 3rd, 2015
13:30 (Registration: 12:45)
Location: Knowledge Theater, Umeda, Osaka
* FREE ADMISSION (limited to first 250)
* Simultaneous interpretation between Japanese and English will be available.
* irdd-poster_A4.pdf
Organized by IAI (6th Division: Division of Innovative
Research for Drug Development)
13:30 Opening Remarks
Toshio Hirano (President, Osaka University)
13:35 Special Guest Remarks
Yutaka Hishiyama
(Deputy Director-General, Office of Healthcare Policy, Cabinet Secretariat)
Masayo Tada
(President, Japan Pharmaceutical Manufacturers Association President & CEO, Dainippon Sumitomo Pharma)
Soichiro Seki
(Director General, Kansai Bureau of Economy, Trade and Industry)
13:50 LECTURES (Introduction)
Takefumi Doi
(Director, 6th Division of IAI / Professor, Graduate School of Pharmaceutical Sciences, Osaka University)
14:00 LECTURES
■ Maree Smith
(Professor, The University of Queensland / Executive Director, TetraQ)
“Therapeutic Innovation Australia-Queensland Node: An Australian Government Initiative for Facilitating Discovery Translation in Universities”
The mission of the Therapeutic Innovation Australia Queensland Node (TIA-QLD Node) is to provide a coordinated and facilitated pathway to assist Australian life sciences discovery researchers to progress their inventions through the various nonclinical and clinical development steps to the point where they will attract investment for commercialization into products for improving human health.
■ Jiye Shi
(Director, Computational Structural Biology at UCB Pharma)
“Antibody Drug Discovery Accelerated by Computational Approaches and Collaborative Efforts”
The development of antibody therapeutics can be greatly accelerated through the applications of advanced computational techniques. A case study will be presented to demonstrate the practical value of this approach, and to discuss the importance of government policy, academic-industrial collaboration and open innovation.
■ Yoshio Matsumi
(CEO, OSAKA University Venture Capital Co., Ltd.)
“Innovation and Drug Discovery & Development in Academia”
Innovation is a key for nation’s economic and societal development. A driving force of innovation is science and technology and the academia plays a vital role in nation’s innovation. The academia’s role is significant in healthcare innovation, drug discovery and development in particular.
There are high expectations on drug discovery and development in the academia.
■ Yoshikatsu Kanai
(Professor, Graduate School of Medicine, Osaka University)
“Innovative drug development targeting transporter molecules
– From discovery of a sugar transporter to the generation of novel antidiabetic drugs – ”
■ Toshihiro Horii
(Professor, Research Institute for Microbial Diseases, Osaka University)
“Clinical Development of Malaria Vaccine BK-SE36”
Malaria is one of three infectious diseases in the world.
We are conducting clinical development of BK-SE36 vaccine to control malaria prevalence.
■ Ryo Kubota
(Founder and Chairman, Acucela)
“Global leadership to foster innovation and role of biotech in the pharmaceutical drug development.”
Malaria is one of three infectious diseases in the world.
We are conducting clinical development of BK-SE36 vaccine to control malaria prevalence.